Virtual Medicinal Product (VMP)
-
Theophylline 175mg modified-release tablets
Name Details
Current Name
Theophylline 175mg modified-release tablets
|
Start Date
07-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release tablet
- Ontology Form/Route
- tabletmodified-release.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
-
R03DA04
BNF |
Current BNF
03010300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
03010300
|
Start Date
31-01-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
35917611000001104 |
19-10-2018 |
|
320416002 |
07-11-2002 |
18-10-2018 |
VMP Ingredients
VMP ingredients table
Theophylline |
Based on Ingredient Substance |
|
175 mg |
|
Name
Theophylline
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
175
Strength and UOM (Dmr)
Parent Products
-
VTM
Theophylline
-
VMP
(Current) Theophylline 175mg modified-release ...
Virtual Medicinal Product Pack (VMPP) Information